Healthcare Playbook Podcast - Cancer Moonshot 1.0 - What's That Look Like?

4min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

There are some interesting initiatives that's happening at the global scale. I'm very excited about actually how AI can really contribute significantly in redefining the healthcare. When you go into some of the drug discovery kind of enabled by the vast amounts of data, which is getting generated when you connect that event to synthetic biology and quantum computing, that's a field of very interest. Within the next 10 years, remote caring would be an important part of care delivery in the United States than what it is today.

This week, we’re super excited to have AmirAli Talasaz, co-CEO and co-founder of Guardant Health, a leading precision oncology company focused on helping conquer cancer globally.

Founded in 2011, Guardant Health is focused on helping conquer cancer through the use of its proprietary blood-based tests, vast data sets and advanced analytics. Guardant’s solutions include treatment selection, recurrence detection and early detection of cancer. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.

Through multiple rounds of private financing, Guardant Health raised over $500 million from investors including Sequoia, Khosla, Lightspeed, OrbiMed, and Softbank, and Pear! and Guardant completed a successful IPO in October 2018.